Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Samsung, Organon, Ewopharma 
Welcome,         Profile    Billing    Logout  

8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Renflexis (infliximab-abda) / Yuhan Corp, Biogen, Ewopharma, Samsung, Organon
2018-001546-33: The effects of switching one drug, used to treat either Ulcerative Colitis (UC) or Crohn’s disease (CD) to another drug, also used to treat UC or Crohn’s disease

Not yet recruiting
4
200
Europe
Flixabi, Infusion, Flixabi
University Southampton Hospital NHS Foundation Trust, Biogen Idec Ltd
Inflammatory Bowel Disease in particular Crohn's Disease and Ulcerative Colitis, Crohn’s Disease: Inflammation of the digestive system or gutUlcerative Colitis: Inflammation and ulceration of the large bowel, Diseases [C] - Digestive System Diseases [C06]
 
 
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Enrolling by invitation
4
148
Europe
Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi
University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
03/25
03/25
CAMEO, NCT05781152: Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Recruiting
4
900
Canada, US
Anti-TNF therapy, Remicade, Inflectra, Renflexis, Avsola, Humira, Amgevita, Hulio, Hadlima, Hyrimoz, Idacio
Connecticut Children's Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Emory University, Children's Hospital Medical Center, Cincinnati, University of North Carolina, Chapel Hill
Crohn Disease
07/28
07/29
REMODEL-CD, NCT05660746: Precise Infliximab Exposure and Pharmacodynamic Control

Recruiting
2/3
180
US
RoadMAB, Infliximab, Avsola, Inflectra, Ixifi, Remicade, Renflexis
Children's Hospital Medical Center, Cincinnati, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Janssen Scientific Affairs, LLC
Crohn Disease
03/27
03/27
NCT04305145: Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Recruiting
2
42
US
Infliximab, AVSOLA, Ixifi, Remicade, Renflexis, Methylprednisolone, Solu-Medrol, Duralone, Medralone, Medrol, M-Prednisol, Prednisone, Deltasone, Prednicot, predniSONE Intensol, Rayos, Sterapred, Sterapred DS
Massachusetts General Hospital, Dana-Farber Cancer Institute
Melanoma Stage III, Melanoma Stage IV, Skin Cancer Stage III, Skin Cancer Stage IV, Drug-Induced Colitis, Drug Toxicity, Immune-related Adverse Event
06/30
06/30
NCT05034536: PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Recruiting
2
36
US
Pembrolizumab, Keytruda, Infliximab, AVSOLA, Ixifi, Remicade, Renflexis, Placebo, Relatlimab, Nivolumab
Massachusetts General Hospital, Massachusetts Institute of Technology
Metastatic Melanoma
06/25
06/26
RUN-CD, NCT03108326: Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

Recruiting
N/A
900
Europe
Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra
Ced Service GmbH
Crohn Disease
03/23
03/23
NeuMRA, NCT04378621: Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients

Active, not recruiting
N/A
212
Europe
TNF-α inhibitor OR JAK inhibitor, TNF-a inhibitors: Etanercept (Enbrel, Benapali), Infliximab (Remicade, Inflectra, Flixabi), Adalimumab (Humira, Imraldi, AMGEVITA), Certolizumabpegol (Cimzia), Golimumab (Simponi), JAK-inhibitors: Baricitinib (Olumiant), Tofacitinib (Xeljanz), Hand training, physiotherapy of hands
Vastra Gotaland Region
Rheumatoid Arthritis, Pain, Fatigue, Cognitive Decline, Depression, Brain Diseases, Hand Rheumatism
09/25
09/25

Download Options